Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T18:27:31.699Z.
Calculation as of: 2026-10-06T18:27:31.699Z.
Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$561.22M
EV/EBIT Ratio
N/A
TTM Avg
14.25x
3Y Avg
18.01x
5Y Avg
18.01x
Market Cap
$576.52M
EV/EBIT Ratio
N/A
TTM Avg
78.65x
3Y Avg
78.65x
5Y Avg
78.65x
Market Cap
$584.34M
EV/EBIT Ratio
N/A
TTM Avg
2.85x
3Y Avg
52.42x
5Y Avg
52.42x
Market Cap
$536.29M
EV/EBIT Ratio
N/A
TTM Avg
189.50x
3Y Avg
189.50x
5Y Avg
189.50x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. (MMEDV) | $560.00M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $561.22M | N/A | 14.25x | 18.01x | 18.01x |
| CorMedix Inc. (CRMD)vs › | $568.28M | 2.10x | 6.25x | 15.98x | 15.98x |
| Monopar Therapeutics Inc. (MNPR)vs › | $547.38M | N/A | N/A | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $576.52M | N/A | 78.65x | 78.65x | 78.65x |
| Shattuck Labs, Inc. (STTK)vs › | $541.32M | N/A | N/A | N/A | N/A |
| ProKidney Corp. (PROK)vs › | $536.32M | N/A | N/A | N/A | N/A |
| Fulgent Genetics, Inc. (FLGT)vs › | $584.34M | N/A | 2.85x | 52.42x | 52.42x |
| Delcath Systems, Inc. (DCTH)vs › | $536.29M | N/A | 189.50x | 189.50x | 189.50x |
| OrthoPediatrics Corp. (KIDS)vs › | $582.61M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
